With 2024 revenue of $247.1 billion and 73,500 employees, Cigna ranks among the largest U.S. corporations. The company operates as an integrated managed care and pharmacy benefits manager, maintaining scale advantage in a consolidating industry while navigating regulatory scrutiny and competitive pressures in healthcare.
Cyborg Score Rationale
Cigna commands substantial scale, diversified revenue streams across medical, dental, pharmacy, and supplemental coverage, and meaningful operating leverage. However, the company faces regulatory headwinds, ongoing healthcare industry consolidation pressures, and public scrutiny around claims denial practices.
Top Insights
Market leader in managed healthcare and insurance with $247.1B in 2024 revenue; ranked #15 in Fortune 500 (2023)
(March 2025) Divested Medicare Advantage and Part D assets to HCSC for $3.7B, narrowing exposure to regulated government programs
Pharmacy benefits management through Express Scripts provides high-margin recurring revenue and integration optionality
Operates across commercial, Medicare Advantage, Medicaid, and international segments, creating resilience but also regulatory complexity
Named Competitors
UnitedHealth Group — Largest managed care and health services company in the U.S.
Anthem — Major health insurance and managed care provider
Aetna — Integrated healthcare with pharmacy benefits and insurance
Humana — Focused managed care provider with Medicare Advantage emphasis
Recent Developments
(January 2024) Agreed to sell Medicare Advantage and Medicare Part D businesses to Health Care Service Corporation for $3.7 billion
(March 2025) HealthSpring sale to HCSC closed, completing strategic focus on commercial and pharmacy-centered platforms